That sounds like more government nonsense. Rather than “rewards,” let the cost of the drugs reflect the expense of developing them, IOW, the free market. Of course, this would reduce the opportunities for graft, which is a major drawback.
From what I have heard people in the US often pay substantially more for the same drug as people in other countries. I find this upsetting. Once again we are financially bearing the burdens of the world and being taken advantage of.